Current Reviews In Clinical And Experimental Pharmacology
  • 数据库收录SCIE
  • 年发文量22

Current Reviews In Clinical And Experimental Pharmacology

期刊中文名:临床和实验药理学最新评论ISSN:2772-4328E-ISSN:2772-4336

该杂志国际简称:CURR REV CLIN EXP PH,是由出版商Bentham出版的一本致力于发布--研究新成果的的专业学术期刊。主要发表刊登有创见的学术论文文章、行业最新科研成果,扼要报道阶段性研究成果和重要研究工作的最新进展,选载对学科发展起指导作用的综述与专论,促进学术发展,为广大读者服务。该刊是一本国际优秀杂志,在国际上有很高的学术影响力。

基本信息:
期刊简称:CURR REV CLIN EXP PH
是否OA:未开放
是否预警:
Gold OA文章占比:4.55%
出版信息:
出版语言:English
出版商:Bentham
评价信息:
JCR分区:Q4
影响因子:1.3
CiteScore:4.8
投稿咨询 加急咨询

发表咨询:400-888-7501

杂志介绍 JCR分区 CiteScore 投稿经验

杂志介绍

Current Reviews In Clinical And Experimental Pharmacology杂志介绍

《Current Reviews In Clinical And Experimental Pharmacology》是一本以English为主的未开放获取国际优秀期刊,中文名称临床和实验药理学最新评论,本刊主要出版、报道领域的研究动态以及在该领域取得的各方面的经验和科研成果,介绍该领域有关本专业的最新进展,探讨行业发展的思路和方法,以促进学术信息交流,提高行业发展。该刊已被国际权威数据库SCIE收录,为该领域相关学科的发展起到了良好的推动作用,也得到了本专业人员的广泛认可。该刊最新影响因子为1.3,最新CiteScore 指数为4.8。

英文介绍

Current Reviews In Clinical And Experimental Pharmacology杂志英文介绍

Current Reviews in Clinical and Experimental Pharmacology is a peer-reviewed journal dedicated to the field of clinical and experimental pharmacology. This magazine aims to provide a platform for publishing review articles on drug mechanisms of action, pharmacodynamics, pharmacokinetics, drug therapy, and new drug development. It covers a wide range of topics from basic research to clinical applications, aiming to promote scientific exchange and knowledge updates in the field of pharmacology. The characteristic of a journal is its comprehensive review of the latest research findings, which is typically based on extensive literature reviews and provides in-depth analysis of specific drug categories or therapeutic fields. This form of article is highly valuable for researchers, clinical doctors, and students as it can help readers quickly grasp the current research status and future directions in a particular field.

The editorial team of the magazine is composed of experienced pharmacologists who ensure that the published articles have high academic standards and practical application value. In addition, journals may regularly invite leading figures in the field to write invited reviews to further enhance their influence in the academic community. It is an important academic resource dedicated to promoting the development of clinical and experimental pharmacology, suitable for professionals seeking in-depth understanding of the latest developments in drug research to read and reference.

JCR分区(2023-2024年最新版)

Current Reviews In Clinical And Experimental Pharmacology杂志 JCR分区信息

按JIF指标学科分区
学科:PHARMACOLOGY & PHARMACY
收录子集:ESCI
分区:Q4
排名:283 / 354
百分位:

20.2%

按JCI指标学科分区
学科:PHARMACOLOGY & PHARMACY
收录子集:ESCI
分区:Q4
排名:267 / 354
百分位:

24.72%

JCR分区:JCR分区来自科睿唯安公司,JCR是一个独特的多学科期刊评价工具,为唯一提供基于引文数据的统计信息的期刊评价资源。每年发布的JCR分区,设置了254个具体学科。JCR分区根据每个学科分类按照期刊当年的影响因子高低将期刊平均分为4个区,分别为Q1、Q2、Q3和Q4,各占25%。JCR分区中期刊的数量是均匀分为四个部分的。

CiteScore 评价数据(2024年最新版)

Current Reviews In Clinical And Experimental Pharmacology杂志CiteScore 评价数据

  • CiteScore 值:4.8
  • SJR:0.44
  • SNIP:0.647
学科类别 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:General Pharmacology, Toxicology and Pharmaceutics Q1 14 / 80

83%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmacology (medical) Q2 106 / 272

61%

历年影响因子和期刊自引率

投稿经验

Current Reviews In Clinical And Experimental Pharmacology杂志投稿经验

该杂志是一本国际优秀杂志,在国际上有较高的学术影响力,行业关注度很高,已被国际权威数据库SCIE收录,该杂志在综合专业领域专业度认可很高,对稿件内容的创新性和学术性要求很高,作为一本国际优秀杂志,一般投稿过审时间都较长,投稿过审时间平均 ,如果想投稿该刊要做好时间安排。版面费不祥。该杂志近两年未被列入预警名单,建议您投稿。如您想了解更多投稿政策及投稿方案,请咨询客服。

免责声明

若用户需要出版服务,请联系出版商。